Announced
Completed
VERONA PHARMA PLC / VIVO CAPITAL LLC / NOVO A/S / Acquisition / Acquisition / Public / £6m
Synopsis
PIPE investment by Novo and Vivo Capital in Verona Pharma, a developer of therapeutic drug treatments for hay fever and other chronic respiratory and inflammatory diseases.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite